Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines.
![Thumbnail](/themes/Mirage2/images/white_rectangle.jpeg)
File Type:
PDFItem Type:
Journal ArticleDate:
2009Author:
Access:
openAccessCitation:
Collins DM, Crown J, O'Donovan N, Devery A, O'Sullivan F, O'Driscoll L, Clynes M, O'Connor R., Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines., Invest New Drugs, 28, 4, 2009, 433 - 444Download Item:
Author's Homepage:
http://people.tcd.ie/lodriscDescription:
PUBLISHED
Author: O'DRISCOLL, LORRAINE
Type of material:
Journal ArticleSeries/Report no:
Invest New Drugs28
4
Availability:
Full text availableDOI:
http://dx.doi.org/10.1007/s10637-009-9266-0Metadata
Show full item recordLicences: